Association between circulating 25-hydroxyvitamin D concentrations and hip replacement for osteoarthritis: a...

Area of Science:

• Orthopedics
• Endocrinology
• Epidemiology

Background:

• Osteoarthritis is a leading cause of hip replacement surgery.
• Circulating vitamin D (25(OH)D) levels are increasingly recognized for their role in bone health.
• The relationship between vitamin D status and osteoarthritis progression requires further elucidation.

Purpose of the Study:

• To investigate the association between circulating 25(OH)D concentrations and the incidence of total hip replacement due to osteoarthritis.
• To explore potential sex differences in this association.

Main Methods:

• Prospective cohort study of 2651 participants from the Melbourne Collaborative Cohort Study.
• Measurement of 25(OH)D concentrations from dried blood spots.
• Linkage to the Australian Orthopaedic Association National Joint Replacement Registry to identify total hip replacement events.
• Cox proportional hazard regression analysis to estimate hazard ratios (HR) and 95% confidence intervals (CI).

Main Results:

• A total of 173 participants (86 men, 87 women) underwent total hip replacement for osteoarthritis.
• In men, higher quartiles of 25(OH)D were associated with an increased risk of total hip replacement (HRs ranging from 1.73 to 2.77 compared to the lowest quartile).
• No significant association was found between 25(OH)D concentrations and total hip replacement risk in women.

Conclusions:

• Elevated circulating 25(OH)D concentrations are associated with a higher risk of total hip replacement for osteoarthritis in men.
• The findings suggest a potential sex-specific role of vitamin D in the pathogenesis or progression of hip osteoarthritis.
• Further research is needed to understand the mechanisms and determine optimal vitamin D levels for reducing osteoarthritis risk.